Cargando…
Type I and type III interferon in opposition?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224133/ https://www.ncbi.nlm.nih.gov/pubmed/32409740 http://dx.doi.org/10.1038/s41577-020-0340-3 |
_version_ | 1783533845457403904 |
---|---|
author | Park, Matthew D. |
author_facet | Park, Matthew D. |
author_sort | Park, Matthew D. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7224133 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-72241332020-05-15 Type I and type III interferon in opposition? Park, Matthew D. Nat Rev Immunol In Brief Nature Publishing Group UK 2020-05-14 2020 /pmc/articles/PMC7224133/ /pubmed/32409740 http://dx.doi.org/10.1038/s41577-020-0340-3 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | In Brief Park, Matthew D. Type I and type III interferon in opposition? |
title | Type I and type III interferon in opposition? |
title_full | Type I and type III interferon in opposition? |
title_fullStr | Type I and type III interferon in opposition? |
title_full_unstemmed | Type I and type III interferon in opposition? |
title_short | Type I and type III interferon in opposition? |
title_sort | type i and type iii interferon in opposition? |
topic | In Brief |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7224133/ https://www.ncbi.nlm.nih.gov/pubmed/32409740 http://dx.doi.org/10.1038/s41577-020-0340-3 |
work_keys_str_mv | AT parkmatthewd typeiandtypeiiiinterferoninopposition |